The oncogenic fusion protein DNAJB1-PRKACA can be actively targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

被引：0

作者：

Bauer, Jens ^{[1
]}

Kohler, Natalie ^{[2
]}

Maringer, Yacine ^{[1
]}

Bucher, Philip ^{[3
]}

Bilich, Tatjana ^{[1
]}

Zwick, Melissa ^{[2
]}

Dicks, Severin ^{[4
]}

Nelde, Annika ^{[1
]}

Dubbelaar, Marissa ^{[1
]}

Scheid, Jonas ^{[1
]}

Wacker, Marcel ^{[1
]}

Heitmann, Jonas J. ^{[1
]}

Schroeder, Sarah ^{[1
]}

Rieth, Jonas ^{[1
]}

Denk, Monika ^{[5
]}

Richter, Marion ^{[5
]}

Klein, Reinhild ^{[1
]}

Bonzheim, Irina ^{[1
]}

Luibrand, Julia ^{[1
]}

Holzer, Ursula ^{[3
]}

Ebinger, Martin ^{[3
]}

Brecht, Ines B. ^{[3
]}

Bitzer, Michael ^{[1
]}

Boerries, Melanie ^{[4
]}

Salih, Helmut R. ^{[1
]}

Rammensee, Hans-Georg ^{[5
]}

Hailfinger, Stephan ^{[6
]}

Walz, Juliane S. ^{[1
]}

机构：

[1] Univ Tubingen Hosp, Tubingen, Germany

[2] Albert Ludwigs Univ, Freiburg, Germany

[3] Univ Childrens Hosp, Tubingen, Germany

[4] Univ Freiburg, Freiburg, Germany

[5] Univ Tubingen, Tubingen, Germany

[6] Univ Hosp Munster, Munster, Germany

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2008

引用

页数：2

共 50 条

[1] The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Jens Bauer
Natalie Köhler
Yacine Maringer
Philip Bucher
Tatjana Bilich
Melissa Zwick
Severin Dicks
Annika Nelde
Marissa Dubbelaar
Jonas Scheid
Marcel Wacker
Jonas S. Heitmann
Sarah Schroeder
Jonas Rieth
Monika Denk
Marion Richter
Reinhild Klein
Irina Bonzheim
Julia Luibrand
Ursula Holzer
Martin Ebinger
Ines B. Brecht
Michael Bitzer
Melanie Boerries
Judith Feucht
Helmut R. Salih
Hans-Georg Rammensee
Stephan Hailfinger
Juliane S. Walz
Nature Communications, 13
[2] The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Bauer, Jens
Koehler, Natalie
Maringer, Yacine
Bucher, Philip
Bilich, Tatjana
Zwick, Melissa
Dicks, Severin
Nelde, Annika
Dubbelaar, Marissa
Scheid, Jonas
Wacker, Marcel
Heitmann, Jonas J.
Schroeder, Sarah
Rieth, Jonas
Denk, Monika
Richter, Marion
Klein, Reinhild
Bonzheim, Irina
Luibrand, Julia
Holzer, Ursula
Ebinger, Martin
Brecht, Ines B.
Bitzer, Michael
Boerries, Melanie
Feucht, Judith
Salih, Helmut R.
Rammensee, Hans-Georg
Hailfinger, Stephan
Walz, Juliane S.
NATURE COMMUNICATIONS, 2022, 13 (01)
[3] Oncogenic Addiction of Fibrolamellar Hepatocellular Carcinoma to the Fusion Kinase DNAJB1-PRKACA
Neumayer, Christoph
Ng, Denise
Jiang, Caroline S.
Qureshi, Adam
Lalazar, Gadi
Vaughan, Roger
Simon, Sanford M.
CLINICAL CANCER RESEARCH, 2023, 29 (01) : 271 - 278
[4] The DNAJB1-PRKACA fusion protein is an immunogenic neoantigen and promising target for immunotherapy in fibrolamellar hepatocellular carcinoma
Bauer, J.
Bilich, T.
Maringer, Y.
Zwick, M.
Koehler, N.
Dubbelaar, M.
Rieth, J.
Nelde, A.
Bitzer, M.
Salih, H. R.
Rammensee, H. -G
Walz, J. S.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 114 - 114
[5] The Role of Kinase Fusion DNAJB1-Prkaca in Fibrolamellar Hepatocellular Carcinoma
Kersten, Cassandra
Shui, Bing
Plummer, Robert
Guo, Lixia
Gregor, Angela
Yang, Yanan
Torbenson, Michael
Peng, Ying
Guo, Yi
HEPATOLOGY, 2018, 68 : 1055A - 1055A
[6] The Role of Kinase Fusion DNAJB1-PRKACA in Fibrolamellar Hepatocellular Carcinoma
Kersten, Cassandra A.
Shui, Bing
Plummer, Robert J.
Guo, Lixia
Gregor, Angela L.
Uy, Kenneth C.
Yang, Yanan
Torbenson, Michael
Peng, Ying
Guo, Yi
HEPATOLOGY, 2017, 66 : 660A - 661A
[7] Biophysical characterization of DNAJB1-PRKACA in Fibrolamellar Hepatocellular Carcinoma
Trung Le Quang Nguyen
FASEB JOURNAL, 2019, 33
[8] DNAJB1-PRKACA is specific for fibrolamellar carcinoma
Graham, Rondell P.
Jin, Long
Knutson, Darlene L.
Kloft-Nelson, Sara M.
Greipp, Patricia T.
Waldburger, Nina
Roessler, Stephanie
Longerich, Thomas
Roberts, Lewis R.
Oliveira, Andre M.
Halling, Kevin C.
Schirmacher, Peter
Torbenson, Michael S.
MODERN PATHOLOGY, 2015, 28 (06) : 822 - 829
[9] Rare case of fibrolamellar variant of hepatocellular carcinoma (HCC) with DNAJB1-PRKACA fusion gene
Frauenfeld, L.
Otto, F.
Fend, F.
VIRCHOWS ARCHIV, 2020, 477 : S215 - S215
[10] GalNAc-conjugated siRNA targeting the DNAJB1-PRKACA fusion junction in fibrolamellar hepatocellular carcinoma
Neumayer, Christoph
Ng, Denise
Requena, David
Jiang, Caroline S.
Qureshi, Adam
Vaughan, Roger
Prakash, Thazha P.
Revenko, Alexey
Simon, Sanford M.
MOLECULAR THERAPY, 2024, 32 (01) : 140 - 151

← 1 2 3 4 5 →